Sinew Pharma Inc.
Sinew Pharma Inc.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Phase 2 | 2026-03-18 | NCT03468556 | |
| To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose | Digestive System Diseases, Hepatic Insufficiency, acute liver failure, hepatitis, liver disorder, liver failure | Recruiting | Phase 2 | 2024-01-10 | NCT05557448 |